Cargando…

Pharmacological Inhibition of LSD1 for Cancer Treatment

Lysine-specific demethylase 1A (LSD1, also named KDM1A) is a demethylase that can remove methyl groups from histones H3K4me1/2 and H3K9me1/2. It is aberrantly expressed in many cancers, where it impedes differentiation and contributes to cancer cell proliferation, cell metastasis and invasiveness, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Guan-Jun, Lei, Pui-Man, Wong, Suk-Yu, Ma, Dik-Lung, Leung, Chung-Hang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320820/ https://www.ncbi.nlm.nih.gov/pubmed/30518104 http://dx.doi.org/10.3390/molecules23123194

Ejemplares similares

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
por: Feng, Zizhen, et al.
Publicado: (2016)

The design and development of covalent protein-protein interaction inhibitors for cancer treatment
por: Cheng, Sha-Sha, et al.
Publicado: (2020)

Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment
por: Cheng, Sha-Sha, et al.
Publicado: (2020)

Mimicking Strategy for Protein–Protein Interaction Inhibitor Discovery by Virtual Screening
por: Wu, Ke-Jia, et al.
Publicado: (2019)

Structure-Based Discovery of a Selective KDM5A Inhibitor that Exhibits Anti-Cancer Activity via Inducing Cell Cycle Arrest and Senescence in Breast Cancer Cell Lines
por: Yang, Guan-Jun, et al.
Publicado: (2019)

Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells
por: Cheng, Shasha, et al.
Publicado: (2021)

Synthesis and Evaluation of Dibenzothiophene Analogues as Pin1 Inhibitors for Cervical Cancer Therapy
por: Wu, Ke-Jia, et al.
Publicado: (2019)

Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B
por: Sang, Na, et al.
Publicado: (2023)

Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells
por: Li, Ting, et al.
Publicado: (2016)

Safety pharmacology of acute LSD administration in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2021)

Pharmacological inhibition of LSD1 activity blocks REST-dependent medulloblastoma cell migration
por: Callegari, Keri, et al.
Publicado: (2018)

Iridium(III) Complexes Targeting Apoptotic Cell Death in Cancer Cells
por: Ma, Dik-Lung, et al.
Publicado: (2019)

Application of iridium(III) complex in label-free and non-enzymatic electrochemical detection of hydrogen peroxide based on a novel “on-off-on” switch platform
por: Miao, Xiangmin, et al.
Publicado: (2016)

Inhibition of the CDK9–cyclin T1 protein–protein interaction as a new approach against triple-negative breast cancer
por: Cheng, Sha-Sha, et al.
Publicado: (2022)

Emerging Screening Approaches in the Development of Nrf2–Keap1 Protein–Protein Interaction Inhibitors
por: Leung, Chung-Hang, et al.
Publicado: (2019)

The emerging role of KDM5A in human cancer
por: Yang, Guan-Jun, et al.
Publicado: (2021)

An Aldol Reaction-Based Iridium(III) Chemosensor for the Visualization of Proline in Living Cells
por: Liu, Jin-Biao, et al.
Publicado: (2016)

The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update
por: Malagraba, Gianluca, et al.
Publicado: (2022)

Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML
por: Nicosia, Luciano, et al.
Publicado: (2021)

Luminescent chemosensors by using cyclometalated iridium(iii) complexes and their applications
por: Ma, Dik-Lung, et al.
Publicado: (2017)

Luminescent turn-on detection of Hg(II) via the quenching of an iridium(III) complex by Hg(II)-mediated silver nanoparticles
por: Liu, Jinshui, et al.
Publicado: (2017)

Ubiquitination Regulators Discovered by Virtual Screening for the Treatment of Cancer
por: Song, Ying-Qi, et al.
Publicado: (2021)

Metal complexes as potential modulators of inflammatory and autoimmune responses
por: Leung, Chung-Hang, et al.
Publicado: (2015)

Comprehensive Quantitative Analysis of 32 Chemical Ingredients of a Chinese Patented Drug Sanhuang Tablet
por: Fung, Hau-Yee, et al.
Publicado: (2017)

Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis
por: Alsaqer, Saqer F., et al.
Publicado: (2017)

Inhibition of Beta-Amyloid Fibrillation by Luminescent Iridium(III) Complex Probes
por: Lu, Lihua, et al.
Publicado: (2015)

A Colorimetric and Luminescent Dual-Modal Assay for Cu(II) Ion Detection Using an Iridium(III) Complex
por: Ma, Dik-Lung, et al.
Publicado: (2014)

A long-lived peptide-conjugated iridium(iii) complex as a luminescent probe and inhibitor of the cell migration mediator, formyl peptide receptor 2
por: Vellaisamy, Kasipandi, et al.
Publicado: (2018)

A Ruthenium(II) Complex Supported by Trithiacyclononane and Aromatic Diimine Ligand as Luminescent Switch-On Probe for Biomolecule Detection and Protein Staining
por: Wong, Chun-Yuen, et al.
Publicado: (2014)

Luminescent Iridium(III) Complexes Supported by N-Heterocyclic Carbene-based C^C^C-Pincer Ligands and Aromatic Diimines
por: Chung, Lai-Hon, et al.
Publicado: (2015)

Natural products as LSD1 inhibitors for cancer therapy
por: Fang, Yuan, et al.
Publicado: (2021)

Structure-guided discovery of a luminescent theranostic toolkit for living cancer cells and the imaging behavior effect
por: Wu, Chun, et al.
Publicado: (2020)

A highly selective, label-free, homogenous luminescent switch-on probe for the detection of nanomolar transcription factor NF-kappaB
por: Ma, Dik-Lung, et al.
Publicado: (2011)

G-quadruplexes for luminescent sensing and logic gates
por: He, Hong-Zhang, et al.
Publicado: (2013)

Development of a luminescent G-quadruplex-selective iridium(III) complex for the label-free detection of adenosine
por: Lu, Lihua, et al.
Publicado: (2016)

Development of Natural Product-Conjugated Metal Complexes as Cancer Therapies
por: Ma, Dik-Lung, et al.
Publicado: (2019)

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
por: De Gregorio, Danilo, et al.
Publicado: (2016)

Discovery of novel sulphonamide hybrids that inhibit LSD1 against bladder cancer cells
por: Liu, Jia, et al.
Publicado: (2022)

Targeting LSD2 in breast cancer
por: Huang, Yi, et al.
Publicado: (2018)

Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies
por: Chao, Angel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jp3ujknr9dfga3jf3d73mb5fm5